Pharma Bio Serv Stock Annual Yield
| PBSV Stock | USD 0.55 0.06 9.84% |
Pharma Bio Serv fundamentals help investors to digest information that contributes to Pharma Bio's financial success or failures. It also enables traders to predict the movement of Pharma OTC Stock. The fundamental analysis module provides a way to measure Pharma Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharma Bio otc stock.
Pharma |
Pharma Bio Serv OTC Stock Annual Yield Analysis
Pharma Bio's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Pharma Bio Annual Yield | 0.06 % |
Most of Pharma Bio's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharma Bio Serv is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Pharma Bio Serv has an Annual Yield of 0.0581%. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The annual yield for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Pharma Fundamentals
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 4.87 M | |||
| Shares Outstanding | 22.95 M | |||
| Shares Owned By Insiders | 64.53 % | |||
| Price To Earning | 10.00 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 0.90 X | |||
| Revenue | 19.4 M | |||
| Gross Profit | 4.88 M | |||
| EBITDA | 1.23 M | |||
| Net Income | 1.01 M | |||
| Cash And Equivalents | 14.24 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 520.77 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 9.07 X | |||
| Book Value Per Share | 0.72 X | |||
| Cash Flow From Operations | 592.46 K | |||
| Earnings Per Share | 0.04 X | |||
| Target Price | 1.77 | |||
| Number Of Employees | 140 | |||
| Beta | 0.36 | |||
| Market Capitalization | 20.88 M | |||
| Total Asset | 20.65 M | |||
| Retained Earnings | 20.5 M | |||
| Working Capital | 20.6 M | |||
| Current Asset | 22.27 M | |||
| Current Liabilities | 1.67 M | |||
| Z Score | 24.0 | |||
| Annual Yield | 0.06 % | |||
| Net Asset | 20.65 M |
About Pharma Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharma Bio Serv's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharma Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharma Bio Serv based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.